Table 2.
Variables at each testing time point, Mean (SD)
| Variables | Group (N) | Week 0 | Week 1 | Week 3 | Week 7 |
|---|---|---|---|---|---|
| NIHSS | AG (120) | 8.33(2.43) | 6.61(2.47) | 4.95(2.44) | 3.48(2.26) |
| NAG (121) | 7.71(2.71) | 6.20(2.69) | 4.43(2.53) | 3.66(2.25) | |
| FMA | AG (120) | 46.12(14.96) | – | 54.21(14.70) | 64.41(14.17) |
| NAG (121) | 50.25(15.90) | – | 57.87(16.84) | 66.85(16.51) | |
| VFSS | AG (68) | 5.26(1.57) | – | – | 9.77(0.45) |
| NAG (65) | 5.55(1.76) | – | – | 9.35(0.77) | |
| MMSE | AG (78) | 20.86(2.64) | – | 22.51(2.67) | 23.80(2.16) |
| NAG (71) | 20.97(2.64) | – | 22.08(2.74) | 23.12(2.95) | |
| MoCA | AG (78) | 18.27(2.01) | – | 20.02(2.34) | 21.51(2.26) |
| NAG (71) | 18.35(2.11) | – | 19.56(2.36) | 20.78(2.45) |
No differences were found between two groups at each testing time point. NIHSS was estimated at week 0 (baseline), week 1 (during the intervention), week 3 (after treatment), and week 7 (follow-up); FMA, MMSE, and MoCA were assessed at week 0, week 3, and week 7; VFSS was evaluated at week 0 and week 7